person

José F. G.

Country
Spain
Department
Servicio de Hematología y Hemoterapia

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
78
Sites with multiple studies

Has run more than one trial at 78 of 205 partner sites.

Specializations

Myelodysplastic Syndromes

The investigator specializes in the treatment of myelodysplastic syndromes (MDS), with particular focus on both higher-risk and lower-risk disease manifestations. Their research encompasses innovative therapeutic approaches for various MDS risk categories.

  • RARA-positive higher-risk MDS
  • Lower-risk MDS management
  • Very low to intermediate risk MDS

Their expertise extends to novel combination treatment strategies and targeted therapies for MDS patients.

Hematologic Conditions

The investigator has developed specialized knowledge in treating anemia associated with myelodysplastic syndromes. Their work involves evaluating novel therapeutic agents aimed at improving hematological parameters in MDS patients.

  • Anemia management in MDS
  • Transfusion dependence
  • Blood disorder therapeutics

Their research focuses on developing solutions for patients with various manifestations of MDS-related anemia.

Novel Therapeutics

The investigator explores innovative treatment approaches for myelodysplastic syndromes, including evaluation of new therapeutic agents such as tamibarotene, KER-050, and AG-946.

  • Targeted therapy development
  • Combination treatment strategies
  • Drug safety assessment

Their work encompasses the investigation of novel compounds for treating various MDS subtypes.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.